Plasma biomarkers of lower gastrointestinal and liver acute GVHD
Andrew C. Harris(Primary Children's Hospital), Sophie Paczesny(MUSC Hollings Cancer Center), Ernst Holler(University Hospital Regensburg), Takanori Teshima(Hokkaido University Hospital), John E. Levine(Icahn School of Medicine at Mount Sinai), Sung Won Choi(University of Michigan), Mark Vander Lugt(Pediatrics and Genetics), Daniel R. Couriel(The University of Texas MD Anderson Cancer Center), Pavan Reddy(Wichita State University), Thomas Braun(University of Michigan), Karin Landfried(University Hospital Regensburg), Koichi Akashi(Kyushu University), James L.M. Ferrara(Tisch Hospital)
Cited by 144
Related Papers
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2020|739
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
|Cancer Cell|2004|701
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
|Frontiers in Immunology|2017|612
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577